Showing results (281-290 of 318) with videos related to
Sort By:
Pageof 32
NAR Genomics and Bioinformatics|August 26, 2024
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinomaOlivia Craig, Samuel Lee, Courtney Pilcher, et al.Journal of Neuro-Oncology|September 11, 2020
Serum microRNA is a biomarker for post-operative monitoring in gliomaAndrew Morokoff, Jordan Jones, Hong Nguyen, et al.The Journal of Clinical Investigation|November 9, 2023
Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature deathDenisa Weis, Liangguang L Lin, Huilun H Wang, et al.Oncotarget|October 28, 2015
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genesSally M Hunter, Michael S Anglesio, Georgina L Ryland, et al.Cancer Cell|July 19, 2002
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)Louise M Kelly, Jin-Chen Yu, Christina L Boulton, et al.Cell Reports|March 2, 2017
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1Simon J Hogg, Stephin J Vervoort, Sumit Deswal, et al.Journal of Neuro-Oncology|October 7, 2020
Correction to: Serum microRNA is a biomarker for post-operative monitoring in gliomaAndrew Morokoff, Jordan Jones, Hong Nguyen, et al.Endocrine-Related Cancer|October 5, 2017
TERT structural rearrangements in metastatic pheochromocytomasTrisha Dwight, Aidan Flynn, Kaushalya Amarasinghe, et al.Molecular Cancer Therapeutics|May 6, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time DependentStacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, et al.Cancer Cell|July 5, 2016
Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid LeukemiaMargherita Ghisi, Lev Kats, Frederick Masson, et al.Pageof 32